2-Deoxyglucose sensitizes melanoma cells to TRAIL-induced apoptosis which is reduced by mannose

Biochemical and Biophysical Research Communications

Volumn 401, Issue 2, 2010, Pages 293-299

  Qin, J Z ^a   Xin, H ^a   Nickoloff, B J ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

2 Deoxyglucose; Death receptor 5; Mannose; Melanoma; TRAIL

Indexed keywords

DEATH RECEPTOR 4; DEATH RECEPTOR 5; DEOXYGLUCOSE; MANNOSE; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CELL LINE, TUMOR; DEOXYGLUCOSE; DRUG RESISTANCE, NEOPLASM; GLUCOSE; HUMANS; MANNOSE; MELANOMA; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 77957777599     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.054     Document Type: Article

References (31)

1. Linos E., Swetter S.M., Cockburn M.G., Colditz G.A., Clarke C.A. Increasing burden of melanoma in the United States. J. Invest. Dermatol. 2009, 129:1666-1674.
2. Haqq C., Nosrati M., Sudilovsky D., Crothers J., Khodabakhsh D., Pulliam B.L., Federman S., Miller J.R., Allen R.E., Singer M.I., Leong S.P., Ljung B.M., Sagebiel R.W., Kashani-Sabet M. The gene expression signatures of melanoma progression. Proc. Natl. Acad. Sci. USA 2005, 102:6092-6097.
3. Houghton A.N., Polsky D. Focus on melanoma. Cancer Cell 2002, 2:275-278.
4. Jones R.G., Thompson C.B. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 2009, 23:537-548.
5. Kroemer G., Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13:472-482.
6. Kelloff G.J., Hoffman J.M., Johnson B., Scher H.I., Siegel B.A., Cheng E.Y., Cheson B.D., O'shaughnessy J., Guyton K.Z., Mankoff D.A., Shankar L., Larson S.M., Sigman C.C., Schilsky R.L., Sullivan D.C. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin. Cancer Res. 2005, 11:2785-2808.
7. Simons A.L., Mattson D.M., Dornfeld K., Spitz D.R. Glucose deprivation-induced metabolic oxidative stress and cancer therapy. J. Cancer Res. Ther. 2009, 5(Suppl. 1):S2-S6.
8. Aravind L., Dixit V.M., Koonin E.V. Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science 2001, 291:1279-1284.
9. Lavrik I.N., Golks A., Krammer P.H. Caspases: pharmacological manipulation of cell death. J. Clin. Invest. 2005, 115:2665-2672.
10. Zhang X.D., Franco A., Myers K., Gray C., Nguyen T., Hersey P. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res. 1999, 59:2747-2753.
11. Ashkenazi A., Herbst R.S. To kill a tumor cell: the potential of proapoptotic receptor agonists. J. Clin. Invest. 2008, 118:1979-1990.
12. Lu M., Strohecker A., Chen F., Kwan T., Bosman J., Jordan V.C., Cryns V.L. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. Clin. Cancer Res. 2008, 14:3168-3176.
13. Wagner K.W., Punnoose E.A., Januario T., Lawrence D.A., Pitti R.M., Lancaster K., Lee D., von Goetz M., Yee S.F., Totpal K., Huw L., Katta V., Cavet G., Hymowitz S.G., Amler L., Ashkenazi A. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat. Med. 2007, 13:1070-1077.
14. Nuutinen U., Simelius N., Ropponen A., Eeva J., Matto M., Eray M., Pellinen R., Wahlfors J., Pelkonen J. PDTC enables type I TRAIL signaling in type II follicular lymphoma cells. Leuk. Res. 2009, 33:829-836.
15. Qin J., Chaturvedi V., Bonish B., Nickoloff B.J. Avoiding premature apoptosis of normal epidermal cells. Nat. Med. 2001, 7:385-386.
16. Lin Y., Liu X., Yue P., Benbrook D.M., Berlin K.D., Khuri F.R., Sun S.Y. Involvement of c-FLIP and survivin down-regulation in flexible heteroarotinoid-induced apoptosis and enhancement of TRAIL-initiated apoptosis in lung cancer cells. Mol. Cancer Ther. 2008, 7:3556-3565.
17. Kim J.Y., Kim E.H., Kim S.U., Kwon T.K., Choi K.S. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation. Carcinogenesis 2010, 31:367-375.
18. Martin V., Garcia-Santos G., Rodriguez-Blanco J., Casado-Zapico S., Sanchez-Sanchez A., Antolin I., Medina M., Rodriguez C. Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death. Cancer Lett. 2010, 287:216-223.
19. Liu H., Jiang C.C., Lavis C.J., Croft A., Dong L., Tseng H.Y., Yang F., Tay K.H., Hersey P., Zhang X.D. 2-Deoxy-d-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2. Mol. Cancer 2009, 8:122.
20. Pradelli L.A., Beneteau M., Chauvin C., Jacquin M.A., Marchetti S., Munoz-Pinedo C., Auberger P., Pende M., Ricci J.E. Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation. Oncogene 2010, 29:1641-1652.
21. Pelicano H., Martin D.S., Xu R.H., Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006, 25:4633-4646.
22. Qin J.Z., Xin H., Nickoloff B.J. Targeting glutamine metabolism sensitizes melanoma cells to TRAIL-induced death. Biochem. Biophys. Res. Commun. 2010, 398:146-152.
23. Dignani J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983, 11:1475-1489.
24. Qin J.Z., Xin H., Sitailo L.A., Denning M.F., Nickoloff B.J. Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA. Cancer Res. 2006, 66:9636-9645.
25. H. Xi, M. Kurtoglu, H. Liu, M. Wangpaichitr, M. You, X. Liu, N. Savaraj, T.J. Lampidis, 2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion, Cancer Chemother. Pharmacol. (2010), in press.
26. Datema R., Schwarz R.T. Formation of 2-deoxyglucose-containing lipid-linked oligosaccharides. Interference with glycosylation of glycoproteins. Eur. J. Biochem. 1978, 90:505-516.
27. Kurtoglu M., Gao N., Shang J., Maher J.C., Lehrman M.A., Wangpaichitr M., Savaraj N., Lane A.N., Lampidis T.J. Under normoxia, 2-deoxy-d-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation. Mol. Cancer Ther. 2007, 6:3049-3058.
28. Vembar S.S., Brodsky J.L. One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell Biol. 2008, 9:944-957.
29. Gonzalvez F., Ashkenazi A. New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 2010, 29:4752-4765.
30. Jiang C.C., Lucas K., Avery-Kiejda K.A., Wade M., de Bock C.E., Thorne R.F., Allen J., Hersey P., Zhang X.D. Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress. Cancer Res. 2008, 68:6708-6717.
31. Tennant D.A., Duran R.V., Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat. Rev. Cancer 2010, 10:267-277.